FDA Approves Propranolol Hydrochloride Application ANDA203103
The FDA has approved the ANDA203103 application for Propranolol Hydrochloride submitted by IPCA Labs Ltd.
Company
Pharmaceutical intelligence for IPCA Labs Ltd. with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
The FDA has approved the ANDA203103 application for Propranolol Hydrochloride submitted by IPCA Labs Ltd.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.